Quantcast

Latest MDV3100 Stories

2009-04-08 13:51:06

U.S.

2009-04-07 15:00:00

- Seminal Research on Prostate Cancer Resistance Leads to Development of MDV3100, Novel Drug Candidate - SAN FRANCISCO, April 7 /PRNewswire-FirstCall/ -- Medivation, Inc.

2009-03-18 08:24:00

SAN FRANCISCO, March 18 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that it has received written permission from the U.S.

2009-02-25 15:01:00

- MDV3100 Consistently Demonstrates Anti-Tumor Activity Across Doses and Endpoints in both Chemotherapy Naive and Post-Chemotherapy Patients - - Data To Be Presented at ASCO's 2009 Genitourinary Cancers Symposium - - Medivation to Host Conference Call and Webcast Presentation with Dr.

2008-10-24 09:00:07

Ariad Pharmaceuticals has reported encouraging preclinical data on the investigational mTOR inhibitor, deforolimus, alone or in combination with the anti-androgen agent, bicalutamide, in models of prostate cancer.

2008-10-23 09:00:39

Medivation, a biopharmaceutical company, has reported new data from an ongoing Phase I-II clinical trial demonstrating that the company's novel androgen receptor antagonist MDV3100 continues to show promising safety and efficacy results.

2008-10-23 09:00:10

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today presented preclinical data on the investigational mTOR inhibitor, deforolimus, alone or in combination with the anti-androgen agent, bicalutamide, in models of prostate cancer.

2008-10-22 09:00:10

GENEVA and SAN FRANCISCO, Oct. 22 /PRNewswire-FirstCall/ -- Medivation, Inc. today announced the presentation of new data from an ongoing Phase 1-2 clinical trial demonstrating that the Company's novel androgen receptor antagonist MDV3100 continues to show promising safety and efficacy results.

2008-10-21 12:00:08

Ariad Pharmaceuticals, a developer of medicines to treat cancer, has announced the initiation of a Phase II clinical trial by Merck & Co to evaluate the safety and efficacy of oral deforolimus, Ariad's investigational mTOR inhibitor, in patients with advanced prostate cancer.


Word of the Day
saggar
  • A ceramic container used inside a fuel-fired kiln to protect pots from the flame.
The word 'saggar' may come from 'safeguard'.
Related